Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNexus Gene Lab (BGLC) Current Deferred Tax Assets (2021)

BioNexus Gene Lab's Current Deferred Tax Assets history spans 1 years, with the latest figure at $67606.0 for Q4 2021.

  • For Q4 2021, Current Deferred Tax Assets changed N/A year-over-year to $67606.0; the TTM value through Dec 2021 reached $67606.0, changed N/A, while the annual FY2021 figure was $67606.0, N/A changed from the prior year.
  • Current Deferred Tax Assets for Q4 2021 was $67606.0 at BioNexus Gene Lab.
  • Across five years, Current Deferred Tax Assets topped out at $67606.0 in Q4 2021 and bottomed at $67606.0 in Q4 2021.